ArticleThe journal of headache and pain2015

A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.

Andrea Negro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.